BIOMAT Database Logo BIOMAT Database Logo

[Case of osteomalacia due to intravenous saccharated ferric oxide]. 1998

T Nakaoka, and T Sugimoto, and Y Okimura, and K Chihara

UI MeSH Term Description Entries
D007262 Infusions, Intravenous The long-term (minutes to hours) administration of a fluid into the vein through venipuncture, either by letting the fluid flow by gravity or by pumping it. Drip Infusions,Intravenous Drip,Intravenous Infusions,Drip Infusion,Drip, Intravenous,Infusion, Drip,Infusion, Intravenous,Infusions, Drip,Intravenous Infusion
D010018 Osteomalacia Disorder caused by an interruption of the mineralization of organic bone matrix leading to bone softening, bone pain, and weakness. It is the adult form of rickets resulting from disruption of VITAMIN D; PHOSPHORUS; or CALCIUM homeostasis. Adult Rickets,Rickets, Adult
D010758 Phosphorus A non-metal element that has the atomic symbol P, atomic number 15, and atomic weight 31. It is an essential element that takes part in a broad variety of biochemical reactions. Black Phosphorus,Phosphorus-31,Red Phosphorus,White Phosphorus,Yellow Phosphorus,Phosphorus 31,Phosphorus, Black,Phosphorus, Red,Phosphorus, White,Phosphorus, Yellow
D005260 Female Females
D005290 Ferric Compounds Inorganic or organic compounds containing trivalent iron. Compounds, Ferric
D005293 Ferritins Iron-containing proteins that are widely distributed in animals, plants, and microorganisms. Their major function is to store IRON in a nontoxic bioavailable form. Each ferritin molecule consists of ferric iron in a hollow protein shell (APOFERRITINS) made of 24 subunits of various sequences depending on the species and tissue types. Basic Isoferritin,Ferritin,Isoferritin,Isoferritin, Basic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000469 Alkaline Phosphatase An enzyme that catalyzes the conversion of an orthophosphoric monoester and water to an alcohol and orthophosphate. EC 3.1.3.1.
D015519 Bone Density The amount of mineral per square centimeter of BONE. This is the definition used in clinical practice. Actual bone density would be expressed in grams per milliliter. It is most frequently measured by X-RAY ABSORPTIOMETRY or TOMOGRAPHY, X RAY COMPUTED. Bone density is an important predictor for OSTEOPOROSIS. Bone Mineral Content,Bone Mineral Density,Bone Densities,Bone Mineral Contents,Bone Mineral Densities,Density, Bone,Density, Bone Mineral

Related Publications

T Nakaoka, and T Sugimoto, and Y Okimura, and K Chihara
Iatrogenic osteomalacia caused by intravenous administration of saccharated ferric oxide.
May 1993, American journal of hematology,
T Nakaoka, and T Sugimoto, and Y Okimura, and K Chihara
Saccharated ferric oxide-induced osteomalacia in Japan: iron-induced osteopathy due to nephropathy.
August 1998, Endocrine journal,
T Nakaoka, and T Sugimoto, and Y Okimura, and K Chihara
A case of osteomalacia due to deranged mineral balance caused by saccharated ferric oxide and short-bowel syndrome: A case report.
September 2017, Medicine,
T Nakaoka, and T Sugimoto, and Y Okimura, and K Chihara
[Case report; A case of FGF23-related hypophosphatemic osteomalacia caused by long-term administration of saccharated ferric oxide].
October 2011, Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine,
T Nakaoka, and T Sugimoto, and Y Okimura, and K Chihara
Oral Ferric Citrate Hydrate Associated With Less Oxidative Stress Than Intravenous Saccharated Ferric Oxide.
March 2018, Kidney international reports,
T Nakaoka, and T Sugimoto, and Y Okimura, and K Chihara
[Knowledge on injectible saccharated ferric oxide].
September 1956, Dansk tidsskrift for farmaci,
T Nakaoka, and T Sugimoto, and Y Okimura, and K Chihara
[Information on injectable saccharated ferric oxide].
November 1956, Pharmaceutica acta Helvetiae,
T Nakaoka, and T Sugimoto, and Y Okimura, and K Chihara
Fibroblast growth factor 23-related osteomalacia caused by the prolonged administration of saccharated ferric oxide.
January 2012, Internal medicine (Tokyo, Japan),
T Nakaoka, and T Sugimoto, and Y Okimura, and K Chihara
A Case of an Insufficiency Fracture of the Medial Proximal Tibia Secondary to Osteomalacia Associated with Long-Term Saccharated Ferric Oxide Administration.
January 2017, Case reports in orthopedics,
T Nakaoka, and T Sugimoto, and Y Okimura, and K Chihara
[2 cases of nonspecific multiple ulcers of the small intestine associated with osteomalacia caused by long-term intravenous administration of saccharated ferric oxide].
November 1982, Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine,
Copied contents to your clipboard!